Advertisement

Tumor Biology

, Volume 35, Issue 1, pp 149–154 | Cite as

CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line

Research Article

Abstract

Caspase recruitment domain-containing membrane-associated guanylate kinase protein 10 or CARMA3 (CARD10) is a recently characterized oncoprotein involved in the progression of several human malignancies. The present study aims to investigate the expression pattern and biological roles of CARMA3 protein in human glioma. CARMA3 expression was analyzed in 97 glioma specimens using immunohistochemistry. We observed negative staining in normal astrocytes and positive staining of CARMA3 in 25 out of 97 (25.8 %) glioma samples. Overexpression of CARMA3 correlated with tumor grade (p < 0.001). Small interfering RNA knockdown was performed in A172 cell line with relatively high CARMA3 expression. Using colony formation assay and Matrigel invasion assay, we showed that CARMA3 depletion in A172 cell line inhibited cell proliferation and cell invasion. In addition, mRNA and protein levels of matrix metallopeptidase 9 (MMP9) were downregulated, indicating CARMA3 might regulate invasion through MMP9. In conclusion, CARMA3 serves as an oncoprotein in human glioma by regulating cell invasion, possibly through MMP9 regulation.

Keywords

CARMA3 Immunohistochemistry Glioma MMP9 

Notes

Conflicts of interest

None.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007;17:304–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Stupp R, Mason WP, van den Bent MJ, Weller M, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.PubMedCrossRefGoogle Scholar
  4. 4.
    Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–8.Google Scholar
  5. 5.
    Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012;138:1971–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Shahi MH, Schiapparelli P, Afzal M, Sinha S, et al. Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors. Tumour Biol. 2011;32:113–27.PubMedCrossRefGoogle Scholar
  7. 7.
    Yang L, Liu M, Gu Z, Chen J, et al. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells. Tumour Biol. 2012;33:2255–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhao T, Miao Z, Wang Z, Xu Y, et al., CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells. Tumour Biol., 2013. doi:10.1007/s13277-013-0869-xGoogle Scholar
  9. 9.
    Miao Z, Zhao T, Wang Z, Xu Y, et al. CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression. Biochem Biophys Res Commun. 2012;425:781–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Li Z, Qu L, Dong Q, Huang B, et al. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One. 2012;7:e36903.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Mahanivong C, Chen HM, Yee SW, Pan ZK, et al. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene. 2008;27:1273–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Wang L, Guo Y, Huang WJ, Ke X, et al. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem. 2001;276:21405–9.PubMedCrossRefGoogle Scholar
  13. 13.
    McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem. 2001;276:30589–97.PubMedCrossRefGoogle Scholar
  14. 14.
    Grabiner BC, Blonska M, Lin PC, You Y, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007;21:984–96.PubMedCrossRefGoogle Scholar
  15. 15.
    McAllister-Lucas LM, Ruland J, Siu K, Jin X, et al. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA. 2007;104:139–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Kim MS, Park MJ, Kim SJ, Lee CH, et al. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int J Oncol. 2005;27:839–46.PubMedGoogle Scholar
  17. 17.
    Dong QZ, Wang Y, Tang ZP, Fu L, et al. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol. 2013;182:954–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Jiang L, Wu J, Yang Y, Liu L, et al. Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer. 2012;12:406.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Sun J. CARMA3: a novel scaffold protein in regulation of NF-kappaB activation and diseases. World J Biol Chem. 2010;1:353–61.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    McAllister-Lucas LM, Jin X, Gu S, Siu K, et al. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J Biol Chem. 2010;285:25880–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Maity G, Choudhury PR, Sen T, Ganguly KK, et al. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2010;32:129–38.PubMedCrossRefGoogle Scholar
  22. 22.
    Guo D, Zhou H, Wu Y, Zhou F, et al. Involvement of ERK1/2/NF-kappaB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumour Biol. 2011;32:921–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Li H, Mittal A, Paul PK, Kumar M, et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem. 2009;284:4439–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, et al. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal. 2009;21:1109–22.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Xingjun Feng
    • 1
  • Guozhuan Miao
    • 1
  • Yipeng Han
    • 1
  • Yi Xu
    • 1
  1. 1.Department of NeurosurgeryGeneral Hospital of Chinese People’s Armed Police ForcesBeijingChina

Personalised recommendations